VetMedGuide

Vet Med Guide

Diagnostics2026-05-16 · 10 min read

Hookworms in Dogs: Fecal Testing, Treatment, Drug Resistance, and the 2026 Update

Hookworms in dogs are harder to treat than they used to be. A guide to diagnosis, the emerging multi-drug resistance crisis, CAPC-recommended protocols, and zoonotic risk.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Hookworms are among the most common intestinal parasites in dogs. Ancylostoma caninum, the predominant species in North America, attaches to the intestinal wall and feeds on blood. In small numbers it may cause no visible signs. In heavy infections — especially in puppies — it can cause life-threatening anemia, hypoproteinemia, and death.

For decades, hookworm treatment was straightforward: a standard dewormer cleared the infection, and monthly preventives kept it from coming back. That is no longer reliably true. Multi-drug-resistant (MADR) A. caninum has emerged as a documented problem in the United States, and in May 2026, the American Association of Veterinary Parasitologists (AAVP) Hookworm Task Force published a comprehensive consensus review in JAVMA with updated diagnostic and treatment recommendations.

This article covers the life cycle, clinical presentation, diagnostic approach, the resistance crisis, current treatment protocols, and zoonotic risk.

The parasites: species that matter

Three hookworm species infect dogs in North America:

  • Ancylostoma caninum — the most common and most pathogenic. Found throughout the US, especially in warm, humid regions. Attaches to the intestinal mucosa with teeth and feeds on blood.
  • Ancylostoma braziliense — found primarily in the southern US and tropical regions. Less pathogenic in dogs but the leading cause of cutaneous larva migrans in humans.
  • Uncinaria stenocephala — the "northern hookworm." Found in cooler climates. Less pathogenic; infections are often subclinical.

A. caninum is the species at the center of the drug resistance crisis, and the rest of this article focuses primarily on it.

How dogs get hookworms

A. caninum has multiple transmission routes, which is one reason it is so persistent:

  • Oral ingestion. Dogs ingest infective larvae from contaminated soil, grass, or feces.
  • Percutaneous penetration. Larvae burrow through the skin, usually through the paws or belly when a dog lies on contaminated ground. The larvae enter the circulation, migrate to the lungs, are coughed up and swallowed, and mature in the small intestine.
  • Transmammary (milk-borne). Dormant larvae in the tissues of a nursing bitch reactivate and are transmitted to puppies through milk. This is the most common route of infection in puppies.
  • Ingestion of paratenic hosts. Dogs can acquire infection by eating rodents or other small animals carrying encysted larvae.

Once in the small intestine, adult hookworms attach to the mucosa, feed on blood, and produce eggs that are passed in feces. Eggs hatch in the environment within 24–48 hours under warm, moist conditions, releasing larvae that develop to the infective stage in 5–7 days.

An important clinical detail: when hookworms are killed by treatment, they detach from the intestinal wall and leave behind ulcerative lesions that continue to bleed for several days. This means a severely anemic dog may actually worsen briefly after treatment before improving. Blood transfusions, iron supplementation, and GI protectants may be needed in severe cases.

Clinical signs

The severity of disease depends on the worm burden, the dog's age, and its immune status:

  • Puppies are most at risk. Heavy infections can cause pale mucous membranes, weakness, rapid breathing, dark tarry stools (melena), failure to thrive, and sudden death. Blood loss can be rapid and severe.
  • Adult dogs with light infections may show no signs. Moderate to heavy infections may cause weight loss, poor coat condition, diarrhea, melena, and mild anemia.
  • Larval skin penetration can cause red, itchy tracks on the paws and belly (cutaneous larva migrans).

Chronic low-grade blood loss from even moderate hookworm burdens can cause iron-deficiency anemia over time, particularly in dogs that are repeatedly reinfected.

Diagnosis

Fecal flotation

The standard diagnostic method is fecal flotation with microscopic identification of hookworm eggs. A. caninum eggs are thin-shelled, oval, and approximately 55–75 micrometers long with a clear space between the developing embryo and the egg wall. They are indistinguishable from A. braziliense and U. stenocephala eggs by routine microscopy.

CAPC recommends fecal testing by centrifugal flotation at least four times in the first year of life for puppies and at least twice annually for adult dogs. According to CAPC's 2026 prevalence data, approximately 1 in 30 dogs tested in the United States is positive for hookworms, with warmer, humid states showing the highest rates.

Fecal antigen testing

Antigen-based tests (such as those included on the IDEXX 4Dx Plus panel) detect hookworm protein in feces. These tests can identify infections even when egg counts are low or intermittent.

Fecal egg count reduction test (FECRT)

The FECRT is the practical tool for identifying drug resistance. A quantitative fecal egg count is performed on the day of treatment and repeated 14 days later:

  • Greater than 95% reduction in egg count indicates effective treatment. Persistent shedding is likely due to larval leak (dormant somatic larvae repopulating the gut) rather than resistance.
  • Less than 75% reduction suggests drug resistance is likely.
  • Between 75% and 95% is equivocal and warrants further investigation.

PCR for resistance markers

PCR testing can detect single nucleotide polymorphisms (SNPs) in the isotype-1 beta-tubulin gene of A. caninum that confer resistance to benzimidazole-class drugs (fenbendazole, febantel). This testing is becoming more widely available through reference laboratories and can help guide treatment decisions.

The drug resistance crisis

This is the most significant change in hookworm management in decades. Here is what the evidence shows:

What happened

Multi-drug resistance in A. caninum is believed to have originated in greyhound racing kennels in the southeastern United States, where intensive and frequent anthelmintic use created strong selection pressure. Racing and recently retired greyhounds remain heavily affected — most carry MADR hookworms — but the problem has spread to the general canine population.

All dog breeds tested have been found to harbor hookworms carrying benzimidazole resistance markers. The resistance extends beyond benzimidazoles: MADR isolates have shown reduced efficacy to pyrantel and potentially other drug classes.

What the 2026 JAVMA Task Force paper says

Published online May 8, 2026, the AAVP Hookworm Task Force consensus review represents the most current expert guidance. Key recommendations include:

  • Confirm resistance before escalating treatment. Use the FECRT to distinguish true drug resistance from larval leak.
  • Triple-drug combination therapy for confirmed resistant cases: a combination of topical moxidectin and an oral tablet containing both pyrantel and febantel (e.g., Advantage Multi + Drontal Plus), all administered at labeled doses within a 24-hour period. The Merck Veterinary Manual also describes an alternative combination of fenbendazole (50 mg/kg PO once daily for 3 days) plus pyrantel pamoate (5 mg/kg PO) plus moxidectin (2.5 mg/kg topical), all given concurrently.
  • Emodepside (off-label oral use) may be considered for cases that fail triple-drug therapy. Dogs must be tested for heartworm infection before receiving emodepside, as the drug has activity against filarid life stages and may cause adverse events in heartworm-positive dogs.
  • Environmental management is essential. Removing feces from the environment prevents reinfection, which can mimic treatment failure.

Why this matters for every dog owner

Even if you do not own a greyhound, the spread of resistant hookworms means that a routine deworming may no longer work. If your dog has been treated for hookworms and a follow-up fecal test is still positive, the issue may not be reinfection — it may be resistance.

Current treatment protocols

Standard (non-resistant) hookworm infections

For routine A. caninum infections with no suspected resistance, multiple approved products are effective:

  • Fenbendazole (Panacur): 50 mg/kg PO once daily for 3 days
  • Pyrantel pamoate: single dose (included in many combination preventives)
  • Febantel + praziquantel + pyrantel (Drontal Plus): single dose
  • Monthly preventives containing milbemycin oxime, moxidectin, or selamectin provide ongoing protection

Because anthelmintics primarily target adult hookworms, treatment typically needs to be repeated at 2–3 week intervals to catch larvae that were in earlier developmental stages during the first round. Monthly preventives then provide ongoing protection against reinfection.

CAPC recommends that all dogs receive year-round broad-spectrum parasite prevention.

Suspected or confirmed resistant infections

  1. Perform a quantitative fecal egg count.
  2. Treat with triple-drug combination (fenbendazole + pyrantel + moxidectin topical).
  3. Repeat fecal egg count at 14 days.
  4. If egg count reduction is less than 75%, confirm resistance and consider emodepside (off-label, in consultation with a parasitologist or infectious disease specialist).
  5. Continue environmental decontamination (prompt feces removal, cleaning concrete runs).
  6. Retest fecal at regular intervals.

Puppies

Because transmammary transmission is the primary route in puppies, deworming should begin early. CAPC and WSAVA guidelines recommend starting anthelmintic treatment at 2 weeks of age, repeating every 2 weeks until 2 weeks after weaning, then transitioning to a monthly preventive.

Zoonotic risk

Hookworms can infect humans through the same percutaneous route as dogs:

  • Cutaneous larva migrans (CLM): Larvae penetrate human skin — usually through bare feet on contaminated sand or soil — causing red, intensely itchy, serpiginous tracks. A. braziliense is the primary causative agent. Beaches and sandboxes are common exposure sites.
  • Eosinophilic enteritis: A. caninum has been identified as a cause of eosinophilic inflammation in the human gut, documented in case reports.

The zoonotic risk reinforces the importance of environmental hygiene. Picking up dog feces promptly, preventing dogs from defecating in children's play areas, and washing hands after handling soil or sand reduce transmission risk.

Fecal testing schedule: what CAPC recommends

  • Puppies: Fecal testing by centrifugal flotation at least 4 times in the first year of life.
  • Adult dogs: Fecal testing at least twice annually.
  • After any hookworm treatment: Follow-up fecal test 14 days after completing treatment to confirm clearance (or to detect resistance early).
  • Dogs with chronic GI signs: More frequent testing may be indicated.

What to ask your veterinarian

  • Was a fecal test done before deworming? Knowing the parasite and the egg count provides a baseline for evaluating treatment success.
  • Should we do a follow-up fecal test after treatment? A 14-day post-treatment fecal is the only way to confirm the drug worked.
  • Is my dog on a monthly preventive that covers hookworms? Most combination heartworm preventives also cover hookworms, but not all do.
  • My dog was treated but still has hookworms. Is it resistance? Ask about the FECRT to distinguish resistance from reinfection or larval leak.

Sources

Topics
Clinical Pathology
Related Articles